Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 3Not yet recruiting 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 62Carcinoma, Non-Small-Cell Lung 45Triple Negative Breast Neoplasms 24Ovarian Neoplasms 20Fallopian Tube Neoplasms 17Neoplasm Metastasis 16Lung Neoplasms 16Endometrial Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Stomach Neoplasms 12Esophageal Neoplasms 10Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Esophageal Squamous Cell Carcinoma 8Colorectal Neoplasms 7Inflammatory Breast Neoplasms 6Head and Neck Neoplasms 6Carcinoma 6Uterine Cervical Neoplasms 5Carcinoma, Ovarian Epithelial 5Melanoma 4Carcinoma, Transitional Cell 4Carcinoma, Squamous Cell 4Adenocarcinoma Of Esophagus 4Urinary Bladder Neoplasms 3Peritoneal Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mouth Neoplasms 3Lung Diseases 3

Interventions

pembrolizumab 5Magnetic Resonance Spectroscopy 5Cisplatin 5Carboplatin 5Specimen Handling 4Radiotherapy, Intensity-Modulated 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4Taxes 2Paclitaxel 2Docetaxel 2peposertib 1ipatasertib 1durvalumab 1dehydroftorafur 1cemiplimab 1atezolizumab 1Zinc Acetate 1X-Rays 1Radiotherapy 1Radiosurgery 1Radiation 1Probiotics 1Observation 1Nutritional Status 1Immunoglobulin G 1Fluorouracil 1Fluorodeoxyglucose F18 1Disulfides 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Laryngeal Neoplasms × Paclitaxel × Clear all
NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04862650 2026-02-10

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
46 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡